Universitätsklinik für Innere Medizin

Klinische Abteilung für Onkologie

SCI/PUBMED gelistet | alle Publikationstypen | Gesamt nach Jahr und Erstautor | MUG-Autor*innen |

** = Publikationen gelistet in SCI/SSCI/Pubmed

Originalarbeit (Zeitschrift)

** Balic, M; Hilbe, W; Gusel, S; Fiegl, M; Ludwig, H; Mayrbaurl, B; Thaler, J; Samonigg, H; Hegenbarth, K; Eisner, F; Mlineritsch, B; Greil, R; Schandl, MJ; Weltermann, A; Petzer, A; Fuchs, D; Stangl, W; Krippl, P; Stauder, R; Stoger, H Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria A cross-sectional multicentre observational study
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00542-7 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Barth, DA; Riedl, JM; Posch, F; Smolle, MA; Kasparek, AK; Niedrist, T; Szkandera, J; Stöger, H; Pichler, M; Stotz, M; Gerger, A Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study.
Clin Transl Oncol. 2019; 21(8):1034-1043 Doi: 10.1007/s12094-019-02037-7 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Callegaro, D; Miceli, R; Bonvalot, S; Ferguson, PC; Strauss, DC; van Praag, VVM; Levy, A; Griffin, AM; Hayes, AJ; Stacchiotti, S; Pèchoux, CL; Smith, MJ; Fiore, M; Tos, APD; Smith, HG; Catton, C; Szkandera, J; Leithner, A; van de Sande, MAJ; Casali, PG; Wunder, JS; Gronchi, A Development and external validation of a dynamic prognostic nomogram for primary extremity soft tissue sarcoma survivors.
EClinicalMedicine. 2019; 17: 100215-100215. Doi: 10.1016/j.eclinm.2019.11.008 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Dieckmann, KP; Radtke, A; Geczi, L; Matthies, C; Anheuser, P; Eckardt, U; Sommer, J; Zengerling, F; Trenti, E; Pichler, R; Belz, H; Zastrow, S; Winter, A; Melchior, S; Hammel, J; Kranz, J; Bolten, M; Krege, S; Haben, B; Loidl, W; Ruf, CG; Heinzelbecker, J; Heidenreich, A; Cremers, JF; Oing, C; Hermanns, T; Fankhauser, CD; Gillessen, S; Reichegger, H; Cathomas, R; Pichler, M; Hentrich, M; Eredics, K; Lorch, A; Wülfing, C; Peine, S; Wosniok, W; Bokemeyer, C; Belge, G Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
J Clin Oncol. 2019; 37(16): 1412-1423. Doi: 10.1200/JCO.18.01480 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, CF; Hlauschek, D; Brown, K; Bernhisel, R; Kronenwett, R; Lancaster, JM; Fitzal, F; Gnant, M Prediction of Distant Recurrence Using EndoPredict Among Women with ER⁺, HER2^- Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.
Clin Cancer Res. 2019; 25(13):3865-3872 Doi: 10.1158/1078-0432.CCR-19-0376 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Fitzal, F; Bjelic-Radisic, V; Knauer, M; Steger, G; Hubalek, M; Balic, M; Singer, C; Bartsch, R; Schrenk, P; Soelkner, L; Greil, R; Gnant, M Impact of Breast Surgery in Primary Metastasized Breast Cancer Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial
ANN SURG. 2019; 269(6): 1163-1169. Doi: 10.1097/SLA.0000000000002771
Web of Science PubMed FullText FullText_MUG

 

** Gebhart, J; Posch, F; Koder, S; Quehenberger, P; Perkmann, T; Kuessel, L; Ay, C; Pabinger, I High risk of adverse pregnancy outcomes in women with a persistent lupus anticoagulant.
Blood Adv. 2019; 3(5): 769-776. Doi: 10.1182/bloodadvances.2018026948 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Gnant, M; Pfeiler, G; Steger, GG; Egle, D; Greil, R; Fitzal, F; Wette, V; Balic, M; Haslbauer, F; Melbinger-Zeinitzer, E; Bjelic-Radisic, V; Jakesz, R; Marth, C; Sevelda, P; Mlineritsch, B; Exner, R; Fesl, C; Frantal, S; Singer, CF, , Austrian, Breast, and, Colorectal, Cancer, Study, Group Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol. 2019; 20(3):339-351 Doi: 10.1016/S1470-2045(18)30862-3
Web of Science PubMed FullText FullText_MUG

 

** Goldzweig, G; Schapira, L; Baider, L; Jacobs, JM; Andritsch, E; Rottenberg, Y Who will care for the caregiver? Distress and depression among spousal caregivers of older patients undergoing treatment for cancer.
Support Care Cancer. 2019; 27(11):4221-4227 Doi: 10.1007/s00520-019-04711-6
Web of Science PubMed FullText FullText_MUG

 

** Grilz, E; Marosi, C; Königsbrügge, O; Riedl, J; Posch, F; Lamm, W; Lang, IM; Pabinger, I; Ay, C Association of complete blood count parameters, d-dimer, and soluble P-selectin with risk of arterial thromboembolism in patients with cancer.
J Thromb Haemost. 2019; 17(8): 1335-1344. Doi: 10.1111/jth.14484 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Grilz, E; Mauracher, LM; Posch, F; Königsbrügge, O; Zöchbauer-Müller, S; Marosi, C; Lang, I; Pabinger, I; Ay, C Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer.
Br J Haematol. 2019; 186(2): 311-320. Doi: 10.1111/bjh.15906 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hell, L; Ay, C; Posch, F; Gebhart, J; Koder, S; Mackman, N; Pabinger, I; Thaler, J Low extracellular vesicle-associated tissue factor activity in patients with persistent lupus anticoagulant and a history of thrombosis.
Ann Hematol. 2019; 98(2):313-319 Doi: 10.1007/s00277-018-3544-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Posch, F; Buser, L; Zigeuner, R; Morshäuser, L; Otto, W; Wild, PJ; Burger, M; May, M; Pichler, M; Brookman-May, SD BioScore (B7-H1, survivin, and Ki-67) does not predict cancer-specific mortality in surgically treated patients with renal cell carcinoma: An external validation study.
Urol Oncol. 2019; 37(7): 510-518. Doi: 10.1016/j.urolonc.2019.04.004
Web of Science PubMed FullText FullText_MUG

 

** Čipak Gašparović, A; Milković, L; Dandachi, N; Stanzer, S; Pezdirc, I; Vrančić, J; Šitić, S; Suppan, C; Balic, M Chronic Oxidative Stress Promotes Molecular Changes Associated with Epithelial Mesenchymal Transition, NRF2, and Breast Cancer Stem Cell Phenotype.
Antioxidants (Basel). 2019; 8(12): 633 Doi: 10.3390/antiox8120633 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Klec, C; Gutschner, T; Panzitt, K; Pichler, M Involvement of long non-coding RNA HULC (highly up-regulated in liver cancer) in pathogenesis and implications for therapeutic intervention.
Expert Opin Ther Targets. 2019; 23(3): 177-186. Doi: 10.1080/14728222.2019.1570499
Web of Science PubMed FullText FullText_MUG

 

** Klec, C; Madreiter-Sokolowski, CT; Ziomek, G; Stryeck, S; Sachdev, V; Duta-Mare, M; Gottschalk, B; Depaoli, MR; Rost, R; Hay, J; Waldeck-Weiermair, M; Kratky, D; Madl, T; Malli, R; Graier, WF Presenilin-1 Established ER-Ca²⁺ Leak: a Follow Up on Its Importance for the Initial Insulin Secretion in Pancreatic Islets and β-Cells upon Elevated Glucose.
Cell Physiol Biochem. 2019; 53(3): 573-586. Doi: 10.33594/000000158 [OPEN ACCESS]
PubMed FullText FullText_MUG

 

** Lembeck, AL; Posch, F; Klocker, EV; Szkandera, J; Schlick, K; Stojakovic, T; Kornprat, P; Lackner, C; Gerger, A; Stoeger, H; Stotz, M; Pichler, M Large platelet size is associated with poor outcome in patients with metastatic pancreatic cancer.
Clin Chem Lab Med. 2019; 57(5):740-744 Doi: 10.1515/cclm-2018-0016
Web of Science PubMed FullText FullText_MUG

 

** Madreiter-Sokolowski, CT; Waldeck-Weiermair, M; Bourguignon, MP; Villeneuve, N; Gottschalk, B; Klec, C; Stryeck, S; Radulovic, S; Parichatikanond, W; Frank, S; Madl, T; Malli, R; Graier, WF Enhanced inter-compartmental Ca²⁺ flux modulates mitochondrial metabolism and apoptotic threshold during aging.
Redox Biol. 2019; 20:458-466 Doi: 10.1016/j.redox.2018.11.003 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Fuchs, J; Pichler, M; Ritter, M; Jakab, M; Helm, K; Neureiter, D; Kiesslich, T Continuous, label-free, 96-well-based determination of cell migration using confluence measurement.
Cell Adh Migr. 2019; 13(1):76-82 Doi: 10.1080/19336918.2018.1526612 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Moik, F; Riedl, JM; Winder, T; Terbuch, A; Rossmann, CH; Szkandera, J; Bauernhofer, T; Kasparek, AK; Schaberl-Moser, R; Reicher, A; Prinz, F; Pichler, M; Stöger, H; Stotz, M; Gerger, A; Posch, F Benefit of second-line systemic chemotherapy for advanced biliary tract cancer: A propensity score analysis.
Sci Rep. 2019; 9(1):5548 Doi: 10.1038/s41598-019-42069-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Müller, HD; Posch, F; Suppan, C; Bargfrieder, U; Gumpoldsberger, M; Hammer, R; Hauser, H; Dandachi, N; Prein, K; Stoeger, H; Lax, S; Balic, M Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy.
Ann Surg Oncol. 2019; 26(13):4274-4283 Doi: 10.1245/s10434-019-07741-w [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pichler, R; Compérat, E; Klatte, T; Pichler, M; Loidl, W; Lusuardi, L; Schmidinger, M Renal Cell Carcinoma with Sarcomatoid Features: Finally New Therapeutic Hope?
Cancers (Basel). 2019; 11(3): 422 Doi: 10.3390/cancers11030422 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Ay, C; Stöger, H; Kreutz, R; Beyer-Westendorf, J Exposure to vitamin k antagonists and kidney function decline in patients with atrial fibrillation and chronic kidney disease.
Res Pract Thromb Haemost. 2019; 3(2): 207-216. Doi: 10.1002/rth2.12189 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Posch, F; Ay, C; Stöger, H; Kreutz, R; Beyer-Westendorf, J Longitudinal kidney function trajectories predict major bleeding, hospitalization and death in patients with atrial fibrillation and chronic kidney disease.
Int J Cardiol. 2019; 282: 47-52. Doi: 10.1016/j.ijcard.2019.01.089
Web of Science PubMed FullText FullText_MUG

 

** Richtig, G; Aigelsreiter, AM; Asslaber, M; Weiland, T; Pichler, M; Eberhard, K; Sygulla, S; Schauer, S; Hoefler, G; Aigelsreiter, A Hedgehog pathway proteins SMO and GLI expression as prognostic markers in head and neck squamous cell carcinoma.
Histopathology. 2019; 75(1):118-127 Doi: 10.1111/his.13860 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Richtig, G; Richtig, E; Böhm, A; Oing, C; Bozorgmehr, F; Kruger, S; Kiesewetter, B; Zielinski, C; Berghoff, AS Awareness of predatory journals and open access among medical oncologists: results of an online survey.
ESMO Open. 2019; 4(6): e000580-e000580. Doi: 10.1136/esmoopen-2019-000580 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Scheithauer, W; Putora, PM; Grünberger, B; Eisterer, W; Wöll, E; Prager, G; Schaberl-Moser, R; Greil, R; Glatzer, M Patterns of care in metastatic pancreatic cancer: patient selection in clinical routine.
Therap Adv Gastroenterol. 2019; 12(5):1756284819877635-1756284819877635 Doi: 10.1177/1756284819877635 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schlick, K; Magnes, T; Huemer, F; Ratzinger, L; Weiss, L; Pichler, M; Melchardt, T; Greil, R; Egle, A C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.
J Clin Med. 2019; 8(11): Doi: 10.3390/jcm8111791 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schmidinger, M; Pichler, R; Loidl, W; Bauernhofer, T; Kretz, M; Tinchon, C; Niedersüß-Beke, D; Pfleger, G; Wiesinger, CG; Vogl, U; Mitterberger, M; Stöger, H; Tulchiner, G; Kratochvill, F; Gerritsmann, H; Mraz, B; Marszalek, M Real-World Evidence Data on Metastatic Renal-Cell Carcinoma Treatment in Austria: The RELACS Study.
Clin Genitourin Cancer. 2019; 17(5):e957-e967-e957-e967 Doi: 10.1016/j.clgc.2019.05.017 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schratter, G; Scheruebel, S; Langthaler, S; Ester, K; Pelzmann, B; Ghaffari-Tabrizi-Wizsy, N; Rezania, S; Gorischek, A; Platzer, D; Zorn-Pauly, K; Ahammer, H; Prokesch, A; Stanzer, S; Devaney, TTJ; Schmidt, K; Jahn, SW; Prassl, R; Bauernhofer, T; Schreibmayer, W; GIRK1 triggers multiple cancer-related pathways in the benign mammary epithelial cell line MCF10A.
SCI REP. 2019; 9: 19277 Doi: 10.1038/s41598-019-55683-w [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schwarzenbacher, D; Klec, C; Pasculli, B; Cerk, S; Rinner, B; Karbiener, M; Ivan, C; Barbano, R; Ling, H; Wulf-Goldenberg, A; Stanzer, S; Rinnerthaler, G; Stoeger, H; Bauernhofer, T; Haybaeck, J; Hoefler, G; Jahn, SW; Parrella, P; Calin, GA; Pichler, M MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Breast Cancer Res. 2019; 21(1): 20-20. Doi: 10.1186/s13058-019-1104-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Singer, CF; Filipits, M; Jahn, SW; Abete, L; Jakesz, R; Greil, R; Bauernhofer, T; Kwasny, W; Seifert, M; Fitzal, F; Kastner, M; Schmitt, M; Moinfar, F; Gnant, M Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Breast. 2019; 46(14):101-107 Doi: 10.1016/j.breast.2019.05.007 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; van Praag, VM; Posch, F; Bergovec, M; Leitner, L; Friesenbichler, J; Heregger, R; Riedl, JM; Pichler, M; Gerger, A; Szkandera, J; Stöger, H; Smolle-Jüttner, FM; Liegl-Atzwanger, B; Fiocco, M; van de Sande, MA; Leithner, A Surgery for metachronous metastasis of soft tissue sarcoma - A magnitude of benefit analysis using propensity score methods.
Eur J Surg Oncol. 2019; 45(2):242-248 Doi: 10.1016/j.ejso.2018.06.019
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C; Brcic, I; Tiran, V; Mueller, HD; Posch, F; Auer, M; Ercan, E; Ulz, P; Cote, RJ; Datar, RH; Dandachi, N; Heitzer, E; Balic, M Untargeted Assessment of Tumor Fractions in Plasma for Monitoring and Prognostication from Metastatic Breast Cancer Patients Undergoing Systemic Treatment.
Cancers (Basel). 2019; 11(8): Doi: 10.3390/cancers11081171 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Terbuch, A; Posch, F; Bauernhofer, T; Pichler, M; Peinsith, H; Szkandera, J; Riedl, J; Hutterer, GC; Pummer, K; Partl, R; Kapp, KS; Stöger, H; Stotz, M; Gerger, A Age as a Predictor of Treatment Outcome in Metastatic Testicular Germ Cell Tumors.
Anticancer Res. 2019; 39(10):5589-5596 Doi: 10.21873/anticanres.13753
Web of Science PubMed FullText FullText_MUG

 

** Ulz, P; Perakis, S; Zhou, Q; Moser, T; Belic, J; Lazzeri, I; Wölfler, A; Zebisch, A; Gerger, A; Pristauz, G; Petru, E; White, B; Roberts, CES; John, JS; Schimek, MG; Geigl, JB; Bauernhofer, T; Sill, H; Bock, C; Heitzer, E; Speicher, MR Inference of transcription factor binding from cell-free DNA enables tumor subtype prediction and early detection.
Nat Commun. 2019; 10(1): 4666-4666. Doi: 10.1038/s41467-019-12714-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Vehabovic-Delic, A; Balic, M; Rossmann, C; Bauernhofer, T; Deutschmann, HA; Schoellnast, H Volume Computed Tomography Perfusion Imaging: Evaluation of the Significance in Oncologic Follow-up of Metastasizing Renal Cell Carcinoma in the Early Period of Targeted Therapy - Preliminary Results.
J Comput Assist Tomogr. 2019; 43(3):493-498 Doi: 10.1097/RCT.0000000000000848
Web of Science PubMed FullText FullText_MUG

 

** Waldeck-Weiermair, M; Gottschalk, B; Madreiter-Sokolowski, CT; Ramadani-Muja, J; Ziomek, G; Klec, C; Burgstaller, S; Bischof, H; Depaoli, MR; Eroglu, E; Malli, R; Graier, WF Development and Application of Sub-Mitochondrial Targeted Ca^{2 +} Biosensors.
Front Cell Neurosci. 2019; 13: 449-449. Doi: 10.3389/fncel.2019.00449 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Richtig, G; Ramelyte, E; Koch, L; Greinix, H; Ferrone, S; Dummer, R; Richtig, E Unmasking of a primary desmoplastic melanoma tumour in the course of treatment of a metastatic disease with anti-PD-1 monoclonal antibody.
J Eur Acad Dermatol Venereol. 2019; 33(10):e381-e383-e381-e383 Doi: 10.1111/jdv.15675 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Absenger, G Resistance to epidermal growth factor receptor tyrosine kinase inhibitors in mutated non-small cell lung cancer: new avenues and strategies to overcome resistance
MEMO-MAG EUR MED ONC. 2019; 12(2): 128-135. Doi: 10.1007/s12254-019-0488-3
Web of Science FullText FullText_MUG

 

** Balic, M; Thomssen, C; Würstlein, R; Gnant, M; Harbeck, N St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment.
Breast Care (Basel). 2019; 14(2):103-110 Doi: 10.1159/000499931 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Barth, DA; Slaby, O; Klec, C; Juracek, J; Drula, R; Calin, GA; Pichler, M Current Concepts of Non-Coding RNAs in the Pathogenesis of Non-Clear Cell Renal Cell Carcinoma.
Cancers (Basel). 2019; 11(10): Doi: 10.3390/cancers11101580 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Hutterer, GC; Pichler, M Advanced/metastatic urothelial carcinoma of the bladder and upper urinary tract Presentation highlights from the ASCO 2019 Congress
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00532-9
Web of Science FullText FullText_MUG

 

** Klec, C; Prinz, F; Pichler, M Involvement of the long noncoding RNA NEAT1 in carcinogenesis.
Mol Oncol. 2019; 13(1):46-60 Doi: 10.1002/1878-0261.12404 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Klec, C; Ziomek, G; Pichler, M; Malli, R; Graier, WF Calcium Signaling in ß-cell Physiology and Pathology: A Revisit.
Int J Mol Sci. 2019; 20(24): Doi: 10.3390/ijms20246110 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Prinz, F; Kapeller, A; Pichler, M; Klec, C The Implications of the Long Non-Coding RNA NEAT1 in Non-Cancerous Diseases.
Int J Mol Sci. 2019; 20(3): Doi: 10.3390/ijms20030627 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Stotz, M; Gerger, A Role of immune checkpoint inhibitors in gastrointestinal cancer treatment
MEMO-MAG EUR MED ONC. 2019; 12(1): 71-76. Doi: 10.1007/s12254-019-0470-0 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Scheipl, S; Liegl-Atzwanger, B; Szkandera, J; Rinner, B; Viertler, C; Friesenbichler, J; Bergovec, M; Leithner, A [Is there a magic bullet for sarcomas? : Personalised treatment for maligant tumours of bone and soft tissue].
Orthopade. 2019; 48(9): 776-783. Doi: 10.1007/s00132-019-03790-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, E; Fink-Neuboeck, N; Lindenmann, J; Smolle-Juettner, F; Pichler, M The Biological and Clinical Relevance of Inhibitor of Growth (ING) Genes in Non-Small Cell Lung Cancer.
Cancers (Basel). 2019; 11(8): Doi: 10.3390/cancers11081118 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Kashofer, K; Riedl, JM; Stotz, M; Gerger, A Genetic Analysis Using a Gene Panel in 87 Caucasian Patients With Colorectal Cancer: Own Results and Review of Literature.
Anticancer Res. 2019; 39(2): 847-852. Doi: 10.21873/anticanres.13184
Web of Science PubMed FullText FullText_MUG

 

** Smolle, MA; Prinz, F; Calin, GA; Pichler, M Current concepts of non-coding RNA regulation of immune checkpoints in cancer.
Mol Aspects Med. 2019; 70:117-126 Doi: 10.1016/j.mam.2019.09.007
Web of Science PubMed FullText FullText_MUG

 

** Suppan, C; Balic, M Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer The best of ASCO 2019
MEMO-MAG EUR MED ONC. 2019; Doi: 10.1007/s12254-019-00530-x [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Wöll, E; Eisterer, W; Gerger, A; Kühr, T; Prager, GW; Rumpold, H; Ulrich-Pur, H; Vogl, U; Winder, T; Weiss, L; Greil, R Treatment Algorithm for Patients With Gastric Adenocarcinoma: An Austrian Consensus on Systemic Therapy.
Anticancer Res. 2019; 39(9): 4589-4596. Doi: 10.21873/anticanres.13638 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Xiao, H; Shiu, PKT; Gabryleska, M; Conn, SJ; Dey, A; Chakrabarti, K; Regouc, M; Pichler, M; Ørom, UAV; Santulli, G; Nishiwada, S; Goel, A; Nagarajan, V; Timmons, L; Alahari, SK; Laprovitera, N; Ferracin, M; Hu, P; Jin, H The Non-Coding RNA Journal Club: Highlights on Recent Papers-7.
Noncoding RNA. 2019; 5(2): 40 Doi: 10.3390/ncrna5020040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Aziz, F; Stelzl, A; Riedl, J; Smolle, M; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Diabetes is a predictor for survival in soft tissue sarcoma patients
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S477-S477. [Poster]
Web of Science

 

** Aziz, F; Stelzl, A; Riedl, JM; Smolle, MA; Stojakovic, T; Posch, F; Terbuch, A; Pichler, M; Leithner, A; Stoger, H; Liegl-Atzwanger, B; Stotz, M; Gerger, A; Szkandera, J; Sourij, H Association of serum glucose levels with disease free survival in soft tissue sarcoma patients
DIABETOLOGIA. 2019; 62: S562-S563.-55th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 16-20, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Balic, M; Suppan, C; Brcic, I; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Dandachi, N Untargeted assessment of tumour fractions in plasma for monitoring and prognostication from metastatic breast cancer patients undergoing systemic treatment
ANN ONCOL. 2019; 30: 110-+.-44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Barth, DA; Riedl, JM; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (lung immune prognostic index) for immunotherapy outcomes in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 108-108. [Poster]
Web of Science

 

** Coronel, DSP; Guglielmetti, DM; Posch, F; Ay, C; Aramberri, M; Zambrano, MDCB; Font, C Performance of the '4S rule' to predict short-term outcomes in cancer outpatients with unsuspected pulmonary embolism
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Dandachi, N; Absenger, G; Brcic, L; Kashofer, K; Terbuch, A; Jaritz, L; Stanzer, S; Balic, M Feasibility and clinical value of serial circulating tumor DNA testing in metastatic lung adenocarcinoma patients undergoing TKI treatment
ONCOL RES TREAT. 2019; 42: 213-213. [Poster]
Web of Science

 

** Dandachi, N; Suppan, C; Brcic, L; Tiran, V; Mueller, DH; Posch, F; Ulz, P; Heitzer, E; Balic, M Monitoring therapy response and assessing prognosis by untargeted FAST-SeqS of circulating tumor DNA in metastatic breast cancer patients
ONCOL RES TREAT. 2019; 42: 41-41. [Poster]
Web of Science

 

** Devyatko, Y; Filipits, M; Greil, R; Balic, M; Bago-Horvath, Z; Singer, C; Fitzal, F; Steger, G; Gray, B; Ferree, S; Fesl, C; Soelkner, L; von Minckwitz, G; Gnant, M The impact of clinical risk assessment versus PAM-50 ROR score on prognosis and therapeutic decision making in patients with hormone-receptor positive early stage breast cancer
CANCER RES. 2019; 79(4): Doi: 10.1158/1538-7445.SABCS18-P1-17-05 [Poster]
Web of Science FullText FullText_MUG

 

** Donsa, K; Stampfer, P; Truskaller, T; Kopanz, J; Konig, C; Lichtenegger, K; Mrak, P; Pinter, G; Schippinger, W; Sinner, F Development of an innovative eHealth System for comprehensive Quality Assurance and Therapy Support in Austrian Institutions of Acute Geriatrics and Remobilization - Presentation of a user-centered Development Process
Z GERONTOL GERIATR. 2019; 52: S158-S158. [Poster]
Web of Science

 

** Fastner, G; Sedlmayer, F; Widder, J; Metz, M; Geinitz, H; Kapp, K; Solkner, L; Greil, R; Jakesz, R; Kwasny, W; Heck, D; Bjelic-Radisic, V; Balic, M; Stoger, H; Wieder, U; Zwrtek, R; Semmler, D; Horvath, W; Melbinger-Zeinitzer, E; Wiesholzer, M; Wette, V; Gnant, M Antihormones with or without irradiation in breast cancer: 10-year results of the ABCSG 8A trial
RADIOTHER ONCOL. 2019; 133: S132-S133.-38th Annual Meeting of the European-Society-for-Radiotherapy-and-Oncology (ESTRO); APR 26-30, 2019; Milan, ITALY. Doi: 10.1016/S0167-8140(19)30690-5 [Poster] [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

** Fediuk, M; Fink-Neubock, N; Maier, A; Lindenmann, J; Balic, M; Smolle-Juttner, FM Bronchial Cancer - personalized
WIEN KLIN WOCHENSCHR. 2019; 131(19-20):508-508. [Oral Communication]
Web of Science

 

** Filipits, M; Dubsky, P; Rudas, M; Greil, R; Balic, M; Fitzal, F; Bago-Horvath, Z; Singer, C; Hlauschek, D; Kronenwett, R; Bernhisel, R; Lancaster, J; Gnant, M Prediction of distant recurrence using EndoPredict among women with ER-positive, HER2-negative breast cancer with a maximum follow-up of 16 years
CANCER RES. 2019; 79(4):-San Antonio Breast Cancer Symposium; DEC 04-08, 2018; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS18-P4-08-05 [Poster]
Web of Science FullText FullText_MUG

 

** Fischer, SC; Tandstad, T; Cohn-Cedermark, GE; Thibault, C; Vincenzi, B; Klingbiel, D; Albany, C; Necchi, A; Terbuch, A; Lorch, A; Aparicio, J; Heidenreich, A; Hentrich, M; Wheater, MJ; Langberg, CW; Stahl, O; Beyer, J; Gillessen, S Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma.
J CLIN ONCOL. 2019; 37(7):-ASCO-GU Genitourinary Cancers Symposium; FEB 15, 2019; San Francisco, CA. Doi: 10.1200/JCO.2019.37.7_suppl.510 [Oral Communication]
Web of Science FullText FullText_MUG

 

** Gampenrieder, SPP; Rinnerthaler, G; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R Impact of pertuzumab and T-DM1 on prognosis of HER2-positive metastatic breast cancer (MBC) and factors affecting their efficacy: Results from the AGMT_MBC-registry
ANN ONCOL. 2019; 30: 126-+.-44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Glantschnig, T; Posch, F; Firla, S; Moik, F; Ablasser, K; Binder, JS; Stoschitzky, G; Wallner, M; Von Lewinski, D; Stoger, H; Zirlik, A; Pichler, M; Rainer, PP Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
WIEN KLIN WOCHENSCHR. 2019; 131: 292-293. [Poster]
Web of Science

 

** Glaser, JM; Rainer, F; Streit, A; Posch, A; Lipp, RW; Kump, P Incidence of Secondary Malignoma in Patients with Gastro-Enteropancreatic Neuroendocrine Neoplasia
NEUROENDOCRINOLOGY. 2019; 108: 62-62. [Poster]
Web of Science

 

** Guglielmetti, DM; Pesantez, D; Posch, F; Ay, C; Aramberri, M; Zambrano, MDCB; Diaz-Pedroche, C; Font, C Short-term outcomes of cancer patients with pulmonary embolism according to the setting (hospital-acquired vs. outpatient) at diagnosis
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Hochmair, MJ; Weinlinger, C; Fabikan, H; Illini, O; Krenbek, D; Setinek, U; Watzka, S; Koger, R; Meilinger, M; Absenger, G; Wanke, M; Semmelweis, C; Rauter, M; Valipour, A Treatment Observations and Clinical Experience with Lorlatinib in Pretreated ALK and ROS1 Rearranged NSCLC Patients
J THORAC ONCOL. 2019; 14(10):S847-S847. Doi: 10.1016/j.jtho.2019.08.1831 [Poster]
Web of Science FullText FullText_MUG

 

** Kocher, F; Seeber, A; Weiss, L; Romeder, F; Szkandera, J; Kuhr, T; Kostner, S; Pichler, P; Jager, T; Greil, R; Brodowicz, T Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.
J CLIN ONCOL. 2019; 37(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 31-JUN 04, 2019; Chicago, IL. [Poster]
Web of Science

 

** Krstic, J; Reinisch, I; Depaoli, M; Berger, N; Noessing, C; Galhuber, M; Anders, I; Auer, M; Moyschewitz, E; Rinner, B; Pichler, M; Malli, R; Prokesch, A Overcoming sorafenib resistance in hepatocellular carcinoma by fasting
BRIT J CANCER. 2019; 121: 16-17. [Oral Communication]
Web of Science FullText

 

** Libiseller, A; Lichtenegger, KM; Kopanz, J; De Campo, A; Wiesinger, T; Weidinger, L; Laubreiter, L; Schippinger, W; Truskaller, T; Lackner, BC; Beck, P; Holl, B; Pieber, TR Improving Glycemic Management of Patients with Type 2 Diabetes in Acute Geriatric Care by Using a Basal Insulin Algorithm Incorporated into a Workflow and Decision Support System
DIABETES. Diabetes 2019 Jun; 68(Supplement 1): -. . 2019; 68: -79th Scientific Sessions of the American-Diabetes-Association (ADA); JUN 07-11, 2019; San Francisco, CA. Doi: 10.2337/db19-952-P [Poster]
Web of Science FullText FullText_MUG

 

** Perakis, SO; Ulz, P; Riedl, JM; Scheipner, L; Kashofer, K; Hoefler, G; Geigl, JB; Speicher, MR; Heitzer, E; Gerger, A Molecular-biological tumor profiling for drug treatment selection in patients with advanced and refractory carcinoma: A prospective, two-stage Phase II individualized cancer treatment study
CANCER RES. 2019; 79(13):-Annual Meeting of the American-Association-for-Cancer-Research (AACR); MAR 29-APR 03, 2019; Atlanta, GA. Doi: 10.1158/1538-7445.AM2019-CT130 [Poster]
Web of Science FullText FullText_MUG

 

** Posch, F; Glantschnig, T; Firla, S; Smolle, M; Balic, M; Moik, F; Stoeger, H; Zirlik, A; Pichler, M; Rainer, P Clinical utility of echocardiographic left-ventricular ejection fraction monitoring for cardiotoxicity risk assessment in patients with HER2+early breast cancer undergoing trastuzumab-based therapy
EUR HEART J. 2019; 40: 3844-3844.-ESC Congress / World Congress of Cardiology; AUG 31-SEP 04, 2019; Paris, FRANCE. [Poster]
Web of Science

 

** Riedl, J; Posch, F; Prager, G; Eisterer, W; Ohler, L; Thamer, S; Wilthoner, K; Petzer, A; Pichler, P; Hubmann, E; Winder, T; Burgstaller, S; Korger, M; Andel, J; Greil, R; Pecherstorfer, M; Philipp-Abbrederis, K; Djanani, A; Gruenberger, B; Langle, F; Woll, E; Gerger, A The AST/ALT (De Ritis) ratio predicts clinical outcome in pancreatic cancer patients treated with first-line nab-paclitaxel and gemcitabine: post-hoc analysis of an Austrian multicenter, non-interventional study
ANN ONCOL. 2019; 30: -European-Society-for-Medical-Oncology (ESMO) 21st World Congress on Gastrointestinal Cancer; JUL 03-06, 2019; Barcelona, SPAIN. Doi: 10.1093/annonc/mdz155.285 [Poster] [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Riedl, JM; Barth, D; Posch, F; Foris, V; Absenger, G; Mollnar, S; Pichler, M; Stotz, M; Stoger, H; Olschewski, H; Gerger, A Longitudinal C-reactive protein (CRP) trajectories predict immune checkpoint inhibitor response and progression in advanced non-small cell lung cancer
ONCOL RES TREAT. 2019; 42: 115-115. [Poster]
Web of Science

 

** Riedl, JM; Barth, DA; Foris, V; Posch, F; Mollnar, S; Stotz, M; Pichler, M; Stoger, H; Absenger, G; Olschewski, H; Gerger, A External validation and longitudinal extension of the LIPI (Lung Immune Prognostic Index) for immunotherapy outcomes in advanced non-small cell lung cancer
ANN ONCOL. 2019; 30: -44th Congress of the European-Society-for-Medical-Oncology (ESMO); SEP 27-OCT 01, 2019; Barcelona, SPAIN. [Poster]
Web of Science

 

** Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Burgstaller, S; Voskova, D; Rossmann, D; Balic, M; Egle, D; Rumpold, H; Singer, CF; Petru, E; Melchardt, T; Ulmer, H; Mlineritsch, B; Greil, R Ixazomib in combination with carboplatin in pretreated women with advanced triple negative breast cancer, an ongoing phase I/II trial (AGMT MBC-10 trial)
CANCER RES. 2019; 79(4):-San Antonio Breast Cancer Symposium; DEC 04-08, 2018; San Antonio, TX. Doi: 10.1158/1538-7445.SABCS18-OT3-07-01 [Poster]
Web of Science FullText FullText_MUG

 

** Rinnerthaler, G; Gampenrieder, SP; Petzer, A; Tinchon, C; Fuchs, D; Balic, M; Heibl, S; Rumpold, H; Egle, D; Zabernigg, AF; Singer, CF; Andel, J; Hubalek, M; Knauer, M; Greil, R First data on overall survival of metastatic breast cancer patients in Austria according to breast cancer subtype: results from the AGMT MBC Registry
ONCOL RES TREAT. 2019; 42: 40-40.
Web of Science

 

** Singer, CF; Oehler, L; Egle, D; Greil, R; Petru, E; Balic, M; Marhold, M; Pfeiler, G; Brunner, C; Kwasny, W; Galid, AA; Tinchon, C; Eisterer, W; Haslbauer, F; Hubalek, M; Redl, A; Hock, K; Hennebelle, M; Mraz, B; Steger, GG REACHAUT: First-line (1L) ribociclib (RIB) plus endocrine therapy (ET) in HR+, HER2-metastatic breast cancer (MBC) in the real-world setting.
J CLIN ONCOL. 2019; 37(15):-Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO); MAY 31-JUN 04, 2019; Chicago, IL. Doi: 10.1200/JCO.2019.37.15_suppl.e12527 [Poster]
Web of Science FullText FullText_MUG

 

** Steger, G; Galid, A; Rechberger, E; Eisterer, W; Herz, W; Petru, E; Pasterk, C; Girschikofsky, M; Singer, C; Grunberger, B; Stoger, H; Marhold, M; Hitzl, D; Lindegger, N Exploring real world data treatment patterns and outcomes in participants with HER2+unresectable LA/mBC - Austrian participation in the prospective European registry SAMANTHA study
ONCOL RES TREAT. 2019; 42: 41-42.
Web of Science

 

** Szkandera, J Which therapies for which molecular subtypes?
ONCOL RES TREAT. 2019; 42: 239-240.
Web of Science

 

** Terzic, J; Fillafer, F; Posch, F; Pichler, R; Seles, M; Niedersuss-Beke, D; Tinchon, C; Loidl, W; Pichler, M; Jahn, S; Stoger, H; Bauernhofer, T; Lymphopenia impairs response to 1st-line tyrosine kinase inhibitor therapy in patients with metastatic clear-cell renal cell carcinoma and modulates the relative efficacy of sunitinib and pazopanib
WIEN KLIN WOCHENSCHR. 2019; 131: S447-S447.-Frühjahrstagung der OeGHO; APR 11-13, 2019; Linz, AUSTRIA. [Poster]
Web of Science FullText

 

** Terzic, J; Tinchon, C; Stoger, H Smoker's Cough - what's behind it?
WIEN KLIN WOCHENSCHR. 2019; 131: S434-S435. [Oral Communication]
Web of Science

 

© Med Uni Graz • Impressum